• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

E3 泛素连接酶复合物的差异招募调节 RET 异构体的内化。

Differential recruitment of E3 ubiquitin ligase complexes regulates RET isoform internalization.

机构信息

Division of Cancer Biology and Genetics, Cancer Research Institute, and Department of Pathology and Molecular Medicine, Queen's University, Kingston ON Canada, K7L 3N6.

Department of Chemistry and Biology, Ryerson University, Toronto, ON, Canada, M5B 2K3.

出版信息

J Cell Sci. 2017 Oct 1;130(19):3282-3296. doi: 10.1242/jcs.203885. Epub 2017 Aug 9.

DOI:10.1242/jcs.203885
PMID:28794017
Abstract

The RET receptor tyrosine kinase is implicated in normal development and cancer. RET is expressed as two isoforms, RET9 and RET51, with unique C-terminal tail sequences that recruit distinct protein complexes to mediate signals. Upon activation, RET isoforms are internalized with distinct kinetics, suggesting differences in regulation. Here, we demonstrate that RET9 and RET51 differ in their abilities to recruit E3 ubiquitin ligases to their unique C-termini. RET51, but not RET9, interacts with, and is ubiquitylated by CBL, which is recruited through interactions with the GRB2 adaptor protein. RET51 internalization was not affected by CBL knockout but was delayed in GRB2-depleted cells. In contrast, RET9 ubiquitylation requires phosphorylation-dependent changes in accessibility of key RET9 C-terminal binding motifs that facilitate interactions with multiple adaptor proteins, including GRB10 and SHANK2, to recruit the NEDD4 ubiquitin ligase. We showed that NEDD4-mediated ubiquitylation is required for RET9 localization to clathrin-coated pits and subsequent internalization. Our data establish differences in the mechanisms of RET9 and RET51 ubiquitylation and internalization that may influence the strength and duration of RET isoform signals and cellular outputs.This article has an associated First Person interview with the first authors of the paper.

摘要

RET 受体酪氨酸激酶参与正常发育和癌症。RET 有两种异构体,即 RET9 和 RET51,它们具有独特的 C 端尾序列,可以招募不同的蛋白复合物来介导信号。激活后,RET 异构体以不同的动力学内化,表明其调节存在差异。在这里,我们证明了 RET9 和 RET51 在招募其独特 C 端的 E3 泛素连接酶的能力上存在差异。RET51 而不是 RET9 与 CBL 相互作用并被其泛素化,CBL 通过与 GRB2 衔接蛋白的相互作用被募集。CBL 敲除不影响 RET51 的内化,但会延迟 GRB2 耗尽细胞中的内化。相比之下,RET9 的泛素化需要 RET9 C 端关键结合基序的磷酸化依赖性变化,以促进与多个衔接蛋白(包括 GRB10 和 SHANK2)的相互作用,从而募集 NEDD4 泛素连接酶。我们表明,NEDD4 介导的泛素化对于 RET9 定位到网格蛋白包被的陷窝和随后的内化是必需的。我们的数据建立了 RET9 和 RET51 泛素化和内化的机制差异,这可能影响 RET 异构体信号的强度和持续时间以及细胞输出。本文附有该论文第一作者的第一人称采访。

相似文献

1
Differential recruitment of E3 ubiquitin ligase complexes regulates RET isoform internalization.E3 泛素连接酶复合物的差异招募调节 RET 异构体的内化。
J Cell Sci. 2017 Oct 1;130(19):3282-3296. doi: 10.1242/jcs.203885. Epub 2017 Aug 9.
2
Distinct turnover of alternatively spliced isoforms of the RET kinase receptor mediated by differential recruitment of the Cbl ubiquitin ligase.由Cbl泛素连接酶的差异募集介导的RET激酶受体可变剪接异构体的独特周转。
J Biol Chem. 2005 Apr 8;280(14):13442-9. doi: 10.1074/jbc.M500507200. Epub 2005 Jan 27.
3
CD2-associated protein (CD2AP) enhances casitas B lineage lymphoma-3/c (Cbl-3/c)-mediated Ret isoform-specific ubiquitination and degradation via its amino-terminal Src homology 3 domains.CD2 相关蛋白(CD2AP)通过其氨基端Src 同源 3 结构域增强 Casitas B 细胞淋巴瘤-3/c(Cbl-3/c)介导的 Ret 异构体特异性泛素化和降解。
J Biol Chem. 2014 Mar 14;289(11):7307-19. doi: 10.1074/jbc.M113.537878. Epub 2014 Jan 14.
4
Distinct Temporal Regulation of RET Isoform Internalization: Roles of Clathrin and AP2.RET 异构体内化的独特时间调控:网格蛋白和 AP2 的作用。
Traffic. 2015 Nov;16(11):1155-73. doi: 10.1111/tra.12315. Epub 2015 Sep 21.
5
Differential expression of RET receptor isoforms in the olfactory system.RET 受体异构体在嗅觉系统中的差异表达。
Neuroscience. 2011 Feb 23;175:49-65. doi: 10.1016/j.neuroscience.2010.11.047. Epub 2010 Nov 28.
6
Phosphotyrosine 1062 is critical for the in vivo activity of the Ret9 receptor tyrosine kinase isoform.磷酸化酪氨酸1062对于Ret9受体酪氨酸激酶同工型的体内活性至关重要。
Mol Cell Biol. 2005 Nov;25(21):9661-73. doi: 10.1128/MCB.25.21.9661-9673.2005.
7
Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas.RET 异构体在正常甲状腺组织、甲状腺乳头状癌和甲状腺髓样癌中的差异表达。
Endocrine. 2019 Sep;65(3):623-629. doi: 10.1007/s12020-019-01957-2. Epub 2019 Jul 5.
8
Alternative splicing results in RET isoforms with distinct trafficking properties.选择性剪接导致 RET 异构体具有不同的运输特性。
Mol Biol Cell. 2012 Oct;23(19):3838-50. doi: 10.1091/mbc.E12-02-0114. Epub 2012 Aug 8.
9
Organotypic specificity of key RET adaptor-docking sites in the pathogenesis of neurocristopathies and renal malformations in mice.神经嵴病变和小鼠肾脏畸形发病机制中关键 RET 衔接蛋白结合位点的器官特异性。
J Clin Invest. 2010 Mar;120(3):778-90. doi: 10.1172/JCI41619. Epub 2010 Feb 15.
10
Grb10/Nedd4-mediated multiubiquitination of the insulin-like growth factor receptor regulates receptor internalization.Grb10/Nedd4介导的胰岛素样生长因子受体多聚泛素化调控受体内化。
J Cell Physiol. 2008 Aug;216(2):426-37. doi: 10.1002/jcp.21405.

引用本文的文献

1
Grb7, Grb10 and Grb14, encoding the growth factor receptor-bound 7 family of signalling adaptor proteins have overlapping functions in the regulation of fetal growth and post-natal glucose metabolism.Grb7、Grb10 和 Grb14 编码生长因子受体结合蛋白 7 家族的信号转导衔接蛋白,在调节胎儿生长和出生后葡萄糖代谢方面具有重叠功能。
BMC Biol. 2024 Sep 30;22(1):221. doi: 10.1186/s12915-024-02018-5.
2
Loss of tumor suppressor TMEM127 drives RET-mediated transformation through disrupted membrane dynamics.抑癌基因 TMEM127 的缺失通过破坏膜动力学驱动 RET 介导的转化。
Elife. 2024 Apr 30;12:RP89100. doi: 10.7554/eLife.89100.
3
Modulating Growth Factor Receptor Signaling to Promote Corneal Epithelial Homeostasis.
调节生长因子受体信号以促进角膜上皮稳态。
Cells. 2023 Nov 29;12(23):2730. doi: 10.3390/cells12232730.
4
TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation.TMEM127 通过促进 RET 泛素化、定位和降解来抑制肿瘤的发展。
Cell Rep. 2023 Sep 26;42(9):113070. doi: 10.1016/j.celrep.2023.113070. Epub 2023 Sep 1.
5
Targeting the RET tyrosine kinase in neuroblastoma: A review and application of a novel selective drug design strategy.针对神经母细胞瘤中的 RET 酪氨酸激酶:一种新型选择性药物设计策略的综述与应用。
Biochem Pharmacol. 2023 Oct;216:115751. doi: 10.1016/j.bcp.2023.115751. Epub 2023 Aug 16.
6
Loss of Tumour Suppressor TMEM127 Drives RET-mediated Transformation Through Disrupted Membrane Dynamics.肿瘤抑制因子TMEM127的缺失通过破坏膜动力学驱动RET介导的细胞转化。
bioRxiv. 2024 Apr 3:2023.06.28.546955. doi: 10.1101/2023.06.28.546955.
7
A RET::GRB2 fusion in pheochromocytoma defies the classic paradigm of RET oncogenic fusions.在嗜铬细胞瘤中发现的 RET::GRB2 融合打破了经典的 RET 致癌融合范例。
Cell Rep Med. 2022 Jul 19;3(7):100686. doi: 10.1016/j.xcrm.2022.100686.
8
RET kinase inhibitors for -altered thyroid cancers.用于RET基因改变的甲状腺癌的RET激酶抑制剂。
Ther Adv Med Oncol. 2022 Jun 21;14:17588359221101691. doi: 10.1177/17588359221101691. eCollection 2022.
9
MAB21L4 Deficiency Drives Squamous Cell Carcinoma via Activation of RET.MAB21L4 缺乏通过激活 RET 驱动鳞状细胞癌。
Cancer Res. 2022 Sep 2;82(17):3143-3157. doi: 10.1158/0008-5472.CAN-22-0047.
10
The Role of NEDD4 E3 Ubiquitin-Protein Ligases in Parkinson's Disease.NEDD4 E3 泛素连接酶在帕金森病中的作用。
Genes (Basel). 2022 Mar 14;13(3):513. doi: 10.3390/genes13030513.